Stock listing
NASDAQ:NVCR NovoCure Limited Stock
Home listing (NASDAQ) of NovoCure Limited
Follow NovoCure Limited into a list and get an email when it puts out news.
Share price · NASDAQ:NVCR
$13.15 USD +0.04 (+0.3%)
Close on Oct 30, 2026
- Day range
- $12.53 – $13.26 USDOct 30, 2026
- Volume
- 1.97M sharesOct 30, 2026
- Market cap
- $1.53B USDAt the close on Oct 30, 2026 · price × 116.4M shares outstanding
- 52-week range
- $9.82 – $21.45 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $22.50M USDMedian day 1.18M shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:NVCR · Home | $13.15 USD | +0.04 (+0.3%) | 1,974,507 | $12.81 | $13.26 | $12.53 | $13.11 | Close on Oct 30, 2026 |
| Frankfurt:038 | €11.55 EUR | -1.385 (-10.7%) | — | €11.55 | €11.55 | €11.55 | €12.93 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:NVCR · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $13.15 | +0.04 | +0.3% | $12.81 | $13.26 | $12.53 | 1,974,507 | |
| $13.11 | -1.06 | -7.5% | $12.90 | $13.85 | $11.85 | 5,953,164 | |
| $14.17 | -0.45 | -3.1% | $14.42 | $14.64 | $13.85 | 2,383,079 | |
| $14.62 | +0.22 | +1.5% | $14.40 | $14.74 | $14.11 | 2,147,157 | |
| $14.40 | -0.28 | -1.9% | $14.47 | $14.90 | $14.20 | 1,166,269 | |
| $14.68 | -0.42 | -2.8% | $14.85 | $14.97 | $14.53 | 1,125,100 | |
| $15.10 | -0.49 | -3.1% | $15.55 | $15.66 | $14.94 | 1,059,800 | |
| $15.59 | -0.12 | -0.8% | $15.60 | $16.09 | $15.43 | 2,599,200 | |
| $15.71 | +0.82 | +5.5% | $14.98 | $15.82 | $14.91 | 1,737,800 | |
| $14.89 | +0.82 | +5.8% | $14.14 | $15.00 | $14.14 | 2,225,000 | |
| $14.07 | -0.34 | -2.4% | $14.41 | $14.41 | $13.88 | 1,287,600 | |
| $14.41 | +0.57 | +4.1% | $13.85 | $14.46 | $13.84 | 1,810,600 | |
| $13.84 | -0.46 | -3.2% | $14.15 | $14.26 | $13.76 | 1,186,000 | |
| $14.30 | -0.42 | -2.9% | $14.66 | $14.75 | $14.29 | 772,600 | |
| $14.72 | +0.14 | +1.0% | $14.54 | $14.76 | $14.26 | 782,000 | |
| $14.58 | +0.36 | +2.5% | $14.17 | $14.78 | $14.14 | 1,022,300 | |
| $14.22 | -0.44 | -3.0% | $14.59 | $14.59 | $13.82 | 2,956,800 | |
| $14.66 | -0.31 | -2.1% | $14.84 | $15.12 | $14.59 | 3,513,300 | |
| $14.97 | -0.23 | -1.5% | $15.27 | $15.88 | $14.90 | 1,763,300 | |
| $15.20 | +0.26 | +1.7% | $14.83 | $15.30 | $14.56 | 1,784,600 | |
| $14.94 | -0.98 | -6.2% | $16.24 | $16.24 | $14.92 | 1,695,100 | |
| $15.92 | -0.03 | -0.2% | $15.81 | $16.44 | $15.77 | 1,208,100 | |
| $15.95 | -0.04 | -0.3% | $16.01 | $16.10 | $15.73 | 1,876,600 | |
| $15.99 | +0.16 | +1.0% | $15.87 | $16.07 | $15.64 | 728,500 | |
| $15.83 | -0.01 | -0.1% | $15.68 | $15.90 | $15.20 | 896,000 | |
| $15.84 | -0.36 | -2.2% | $16.20 | $16.27 | $15.82 | 1,028,000 | |
| $16.20 | -0.05 | -0.3% | $16.43 | $16.43 | $15.73 | 1,142,600 | |
| $16.25 | -0.42 | -2.5% | $16.53 | $16.75 | $15.97 | 777,700 | |
| $16.67 | +0.14 | +0.8% | $16.70 | $16.79 | $16.54 | 1,044,600 | |
| $16.53 | -0.16 | -1.0% | $16.87 | $16.87 | $16.37 | 633,500 | |
| $16.69 | -0.03 | -0.2% | $16.70 | $16.87 | $16.53 | 1,152,700 | |
| $16.72 | +0.50 | +3.1% | $16.58 | $16.99 | $16.13 | 1,482,600 | |
| $16.22 | +0.07 | +0.4% | $16.18 | $16.55 | $16.01 | 1,639,300 | |
| $16.15 | -0.07 | -0.4% | $16.13 | $16.66 | $15.96 | 914,800 | |
| $16.22 | +0.71 | +4.6% | $15.49 | $16.25 | $15.29 | 1,049,300 | |
| $15.51 | +0.16 | +1.0% | $15.50 | $16.00 | $15.35 | 1,127,200 | |
| $15.35 | -0.28 | -1.8% | $15.26 | $16.07 | $15.10 | 1,385,200 | |
| $15.63 | -1.22 | -7.2% | $16.56 | $16.65 | $15.60 | 995,500 | |
| $16.85 | -1.09 | -6.1% | $17.64 | $17.78 | $16.57 | 1,459,700 | |
| $17.94 | +0.30 | +1.7% | $17.53 | $18.02 | $17.47 | 732,000 | |
| $17.64 | -0.19 | -1.1% | $17.94 | $18.05 | $17.42 | 613,400 | |
| $17.83 | +0.45 | +2.6% | $17.88 | $18.59 | $17.50 | 1,324,000 | |
| $17.38 | -0.27 | -1.5% | $17.36 | $17.88 | $17.29 | 800,300 | |
| $17.65 | -0.17 | -1.0% | $17.55 | $17.97 | $17.39 | 914,800 | |
| $17.82 | -0.17 | -0.9% | $17.99 | $18.16 | $17.42 | 855,600 | |
| $17.99 | +0.10 | +0.6% | $17.92 | $18.21 | $17.48 | 763,400 | |
| $17.89 | +0.27 | +1.5% | $17.43 | $17.97 | $17.15 | 1,270,900 | |
| $17.62 | +0.86 | +5.1% | $16.98 | $17.64 | $16.92 | 902,900 | |
| $16.76 | -0.34 | -2.0% | $17.02 | $17.06 | $16.33 | 1,607,200 | |
| $17.10 | -0.67 | -3.8% | $17.75 | $17.83 | $17.01 | 1,403,800 | |
| $17.77 | -0.43 | -2.4% | $18.12 | $18.61 | $17.48 | 955,700 | |
| $18.20 | +0.96 | +5.6% | $17.40 | $18.34 | $17.38 | 4,838,600 | |
| $17.24 | -0.29 | -1.7% | $17.25 | $17.73 | $17.08 | 792,600 | |
| $17.53 | +0.58 | +3.4% | $16.78 | $17.76 | $16.78 | 1,448,900 | |
| $16.95 | -0.43 | -2.5% | $17.23 | $17.23 | $16.80 | 681,200 | |
| $17.38 | -0.21 | -1.2% | $17.53 | $17.75 | $17.18 | 637,100 | |
| $17.59 | -0.07 | -0.4% | $17.66 | $17.68 | $17.22 | 764,500 | |
| $17.66 | +0.35 | +2.0% | $17.34 | $17.83 | $17.29 | 923,700 | |
| $17.31 | +0.92 | +5.6% | $16.27 | $17.59 | $16.27 | 1,045,100 | |
| $16.39 | +0.70 | +4.5% | $15.60 | $16.42 | $15.60 | 1,529,200 | |
| $15.69 | -0.36 | -2.2% | $16.20 | $16.20 | $15.58 | 943,300 | |
| $16.05 | -0.22 | -1.4% | $16.14 | $16.25 | $15.93 | 1,234,100 | |
| $16.27 | +0.95 | +6.2% | $15.28 | $16.30 | $15.23 | 1,740,200 | |
| $15.32 | +0.48 | +3.2% | $15.00 | $15.69 | $15.00 | 1,642,900 | |
| $14.84 | -0.39 | -2.6% | $15.46 | $15.73 | $14.83 | 1,228,600 | |
| $15.23 | +0.03 | +0.2% | $15.20 | $15.49 | $15.05 | 1,414,700 |
- Ticker
- NASDAQ:NVCR
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 29, 2026
Novocure Reports Third Quarter 2026 Financial Results and Raises 2026 Guidance
Latest earnings call · Oct 29, 2026
Novocure (NASDAQ:NVCR) Q3 2026 Earnings Call
Replay and transcript
Latest deck · Jul 23, 2026
Q2 2026 Earnings Presentation
Earnings · 12 slides
Calls
Replays
Novocure (NASDAQ:NVCR) Q3 2026 Earnings Call
Thu, Oct 29, 2026 · 8:00 AM ET
Watch TranscriptNovocure (NASDAQ:NVCR) Q2 2026 Earnings Call
Thu, Jul 23, 2026 · 8:00 AM ET
Watch TranscriptNovocure (NASDAQ:NVCR) Q1 2026 Earnings Call
Thu, Apr 30, 2026 · 8:00 AM ET
Watch Transcript
Latest news
Novocure Reports Third Quarter 2026 Financial Results and Raises 2026 Guidance
Oct 29, 2026
Closed $13.11 (-7.5%) on Oct 29, 2026
Novocure to Evaluate Tumor Treating Fields Therapy with VS-7375, an Oral KRAS G12D (ON/OFF) Inhibitor, to Treat Pancreatic Cancer Through Clinical Trial Collaboration and Supply Agreement
Oct 28, 2026
Closed $14.17 (-3.1%) on Oct 28, 2026
Novocure’s Optune Pax® Receives Approval in Japan for the Treatment of Unresectable Locally Advanced Pancreatic Cancer
Oct 1, 2026
Closed $15.92 (-0.2%) on Oct 1, 2026
Novocure to Report Third Quarter 2026 Financial Results
Oct 1, 2026
Closed $15.92 (-0.2%) on Oct 1, 2026
Novocure Reports Second Quarter 2026 Financial Results
Jul 23, 2026
Closed $19.99 (+28.4%) on Jul 23, 2026
Novocure to Report Second Quarter 2026 Financial Results
Jul 1, 2026
Closed $15.78 (+4.2%) on Jul 1, 2026
Novocure’s Optune Pax® Receives CE Mark for the Treatment of Locally Advanced Pancreatic Cancer
Jun 30, 2026
Closed $15.15 (-2.1%) on Jun 30, 2026
Novocure Announces Topline Data from the Phase 3 TRIDENT Trial Evaluating Earlier Use of Tumor Treating Fields Therapy in Newly Diagnosed Glioblastoma
Jun 18, 2026
Closed $14.28 (-20.0%) on Jun 18, 2026
Novocure Reports First Quarter 2026 Financial Results
Apr 30, 2026
Closed $15.21 (+27.5%) on Apr 30, 2026
Novocure to Report First Quarter 2026 Financial Results
Apr 1, 2026
Closed $10.84 (-0.6%) on Apr 1, 2026
Decks
Q2 2026 Earnings Presentation
Earnings · 12 slides · Jul 23, 2026
Investor Presentation (July 2026)
Investor deck · 15 slides · July 2026
Q1 2026 Earnings Presentation
Earnings · 12 slides · Apr 30, 2026
Q4 2025 Earnings Presentation
Earnings · 12 slides · Feb 26, 2026
NovoCure Limited on 6ix
- News releases
- 21 in the last 12 months · 189 in all · newest Oct 29, 2026 · oldest 2020
- Calls
- 25 calls with a replay · 25 with a transcript · latest Oct 29, 2026
- Decks
- 22 decks · latest Jul 23, 2026
Where NovoCure Limited is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:NVCR · Home listing · This page | NASDAQ | United States | USD |
| gettex:038 | gettex | Germany | EUR |
| LS Exchange:A140ML | LS Exchange | Germany | EUR |
| BOATS:NVCR | BOATS | United States | USD |
| Lang & Schwarz:A140ML | Lang & Schwarz | Germany | EUR |
| B3:N2VC34 | B3 | Brazil | BRL |
| Tradegate:038 | Tradegate | Germany | EUR |
| BMV:NVCRN | BMV | Mexico | MXN |
| BIVA:NVCRN | BIVA | Mexico | MXN |
| Frankfurt:038 | Frankfurt | Germany | EUR |
| Dusseldorf:038 | Dusseldorf | Germany | EUR |
| Munich:038 | Munich | Germany | EUR |
| Stuttgart:038 | Stuttgart | Germany | EUR |
Log in to ask 6ix AI your own questions about NovoCure Limited.